| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 79525-56-7 | Cyclo(glycylglycyl-L-phenylalanyl-L-leucyl-L-lysyl-L-lysyl-L-tyrosyl)(9CI); Cyclic(glycylglycyl-L-phenylalanyl-L-leucyl-L-lysyl-L-lysyl-L-tyrosyl); 1,4,7,10,13,16,19-Heptaazacycloheneicosane, cyclic peptide deriv. | ![]() | C40H59N9O8 | 详情 | 供应商 | |
| 71901-21-8 | L-lysine,N-formyl-L-norleucyl-L-leucyl-L-phenylalanyl-L-norleucyl-L-tyrosyl-; L-lysine,N2-[N-[N-[N-[N-(N-formyl-L-norleucyl)-L-leucyl]-L-phenylalanyl]-L-norleucyl]-L-tyrosyl]-; N-Formyl-Nle-leu-Phe-Nle-tyr-lys; N-Formyl-norleucyl-leucyl-phenylalanyl-norleucyl-tyrosyl-lysine | ![]() | C43H65N7O9 | 详情 | 供应商 | |
| 83404-43-7 | L-lysine,L-tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-; 1-7-a-Neoendorphin (swine),6-de-L-arginine- (9CI); a-Neoendorphin (pig), 6-de-L-arginine-8-de-L-tyrosine-9-de-L-proline-10-de-L-lysine-; 204: PN: WO0069900 SEQID: 876 unclaimed sequence; 45: PN: WO0222860 SEQID: 42unclaimed sequence; 701: PN: US20090175821 SEQID: 876 claimed protein; [leu5-lys6]enkephalin | ![]() | C34H49N7O8 | 详情 | 供应商 | |
| 5915-09-3 | L-Methioninamide,L-asparaginyl-L-lysyl-L-phenylalanyl-L-tyrosylglycyl-L-leucyl- (9CI); Methioninamide,L-asparaginyl-L-lysyl-L-phenylalanyl-L-tyrosylglycyl-L-leucyl-, L- (7CI,8CI) | ![]() | C41H62N10O9S | 详情 | 供应商 | |
| 75106-72-8 | L-Arginine,L-tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-L-arginyl-L-lysyl-; L-Arginine,N2-[N2-[N2-[N-[N-[N-(N-L-tyrosylglycyl)glycyl]-L-phenylalanyl]-L-leucyl]-L-arginyl]-L-lysyl]-; 158: PN: WO0069900 SEQID: 823 unclaimed sequence; 669: PN: US20090175821 SEQID:823 claimed protein; a-Neoendorphin 1-8 (porcine) | ![]() | C46H73N15O10 | 详情 | 供应商 | |
| 13198-06-6 | L-Methioninamide,L-prolyl-L-asparaginyl-L-lysyl-L-phenylalanyl-L-tyrosylglycyl-L-leucyl- (9CI); Methioninamide,L-prolyl-L-asparaginyl-L-lysyl-L-phenylalanyl-L-tyrosylglycyl-L-leucyl-, L-(7CI,8CI); Physalemin, 1-de(5-oxo-L-proline)-2-de-L-alanine-3-de-L-asparticacid- | ![]() | C46H69N11O10S | 详情 | 供应商 | |
| 137061-48-4 | 腺苷酸环化酶激活肽-38(抗原) | H-HIS-SER-ASP-GLY-ILE-PHE-THR-ASP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-AL; H-HIS-SER-ASP-GLY-ILE-PHE-THR-ASP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-ala-VAL-leu-GLY-lys-ARG-tyr-lys-GLN-ARG-VAL-lys-ASN-lys-NH2; HIS-SER-ASP-GLY-ILE-PHE-THR-ASP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-ala-VAL-leu-GLY-lys-ARG-tyr-lys-GLN-ARG-VAL-lys-ASN-lys-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 无 | C203H331N63O53S1 | 详情 | 供应商 |
| 866552-34-3 | HIS-ala-ASP-ala-VAL-PHE-THR-ala-ala-tyr-ala-ARG-leu-ARG-lys-GLN-MET-ala-ala-lys-lys-ala-leu-ala-ala-; [ala2,8,9,11,19,22,24,25,27,28]-VIP; HIS-ala-ASP-ala-VAL-PHE-THR-ala-ala-tyr-ala-ARG-leu-ARG-lys-GLN-MET-ala-ala-lys-lys-ala-leu-ala-ala-ILE-ala-ala-NH2 | ![]() | C131H219N41O33S | 详情 | 供应商 | |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ala-GLU-PHE-ARG-HIS-ASP-SER-GLY-tyr-GLU-VAL-HIS-HIS-GLN-lys-leu-VAL-PHE-PHE-ala-GLU-ASP-VAL-GL; PREDOMINANT AMYLOID B-PROTEIN FRAGMENT; ASP-ala-GLU-PHE-ARG-HIS-ASP-SER-GLY-tyr-GLU-VAL-HIS-HIS-GLN-lys-leu-VAL-PHE-PHE-ala-GLU-ASP-VAL-GLY-SER-ASN-lys-GLY-ala-ILE-ILE-GLY-leu-MET-VAL-GLY-GLY-VAL-VAL-ILE-ala; ASP-ala-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-VAL-ARG-HIS-GLN-lys-leu-VAL-PHE-PHE-ala-GLU-ASP-VAL-GLY-SER-ASN-lys-GLY-ala-ILE-ILE-GLY-leu-MET-VAL-GLY-GLY-VAL-VAL-ILE-ala; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 无 | C203H311N55O60S | 详情 | 供应商 |
| 125093-93-8 | VIP ANTAGONIST | H-lys-PRO-ARG-ARG-PRO-tyr-THR-ASP-ASN-tyr-THR-ARG-leu-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ASN-SE; H-lys-PRO-ARG-ARG-PRO-tyr-THR-ASP-ASN-tyr-THR-ARG-leu-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ASN-SER-ILE-leu-ASN-NH2; KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2; VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST; VIP ANTAGONIST; (lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P; (lys1 PRO2 5 ARG3 4 tyr6)-VASOACTIVE &; (VIP-neurotensin) hybrid antagonist; H-lys-Pro-Arg-Arg-Pro-tyr-Thr-Asp-Asn-tyr-Thr-Arg-leu-Arg-lys-Gln-Met-ala-Val-lys-lys-tyr-leu-Asn-Ser-Ile-leu-Asn-NH2 | ![]() | C154H257N49O40S | 详情 | 供应商 |
| 383415-79-0 | TRP-tyr-lys-HIS-VAL-ala-SER-PRO-ARG-tyr-HIS-THR-VAL-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu | H-TRP-tyr-lys-HIS-VAL-ala-SER-PRO-ARG-tyr-HIS-THR-VAL-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu-OH; NPW-23 (HUMAN); NEUROPEPTIDE W-23 (HUMAN); TRP-tyr-lys-HIS-VAL-ala-SER-PRO-ARG-tyr-HIS-THR-VAL-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu; H-TRP-tyr-lys-HIS-VAL-ala-SER-PRO-ARG-tyr-HIS-THR-VAL-GLY-ARG-ala-ala-GLY-leu-leu-MET-GLY-leu-OH | ![]() | C119H183N35O28S | 详情 | 供应商 |
| 205640-90-0 | OREXIN A (HUMAN, BOVINE, CANINE, MOUSE, OVINE, PORCINE, RAT) | PYR-PRO-leu-PRO-ASP-CYS-CYS-ARG-GLN-lys-THR-CYS-SER-CYS-ARG-leu-tyr-GLU-leu-leu-HIS-GLY-ala-GLY-ASN-; HYPOCRETIN; PYR-PRO-leu-PRO-ASP-CYS-CYS-ARG-GLN-lys-THR-CYS-SER-CYS-ARG-leu-tyr-GLU-leu-leu-HIS-GLY-ala-GLY-ASN-HIS-ala-ala-GLY-ILE-leu-THR-leu-NH2; PYR-PRO-leu-PRO-ASP-CYS-CYS-ARG-GLN-lys-THR-CYS-SER-CYS-ARG-leu-tyr-GLU-leu-leu-HIS-GLY-ala-GLY-ASN-HIS-ala-ala-GLY-ILE-leu-THR-leu-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); PYR-PLPDCCRQKTCSCRLYELLHAGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); OREXINS OREXIN A HUMAN, RAT, MOUSE; OREXIN A, BOVINE, HUMAN, MOUSE, RAT | ![]() | C152H247N47O44S4 | 详情 | 供应商 |
| 143748-18-9 | PACAP (6-38), HUMAN, OVINE, RAT | H-PHE-THR-ASP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-ala-VAL-leu-GLY-lys-AR; FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; HIS-SER-ASP-GLY-ILE-PHE-THR-AP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-ala-VAL-leu-GLY-lys-ARG-tyr-lys-GLN-ARG-VAL-lys-ASN-lys-NH2; H-PHE-THR-ASP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-ala-VAL-leu-GLY-lys-ARG-tyr-lys-GLN-ARG-VAL-lys-ASN-lys-NH2; PHE-THR-ASP-SER-tyr-SER-ARG-tyr-ARG-lys-GLN-MET-ala-VAL-lys-lys-tyr-leu-ala-ala-VAL-leu-GLY-lys-ARG-tyr-lys-GLN-ARG-VAL-lys-ASN-lys-NH2; PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT) | ![]() | C203H331N63O65S | 详情 | 供应商 |
| 126339-09-1 | ala-lys-PRO-GLU-ala-PRO-GLY-GLU-ASP-ala-SER-PRO-GLU-GLU-leu-SER-ARG-tyr-tyr-ala-SER-leu-ARG-HIS-tyr-; ala-lys-PRO-GLU-ala-PRO-GLY-GLU-ASP-ala-SER-PRO-GLU-GLU-leu-SER-ARG-tyr-tyr-ala-SER-leu-ARG-HIS-tyr-leu-ASN-leu-VAL-THR-ARG-GLN-ARG-tyr-NH2; PEPTIDE YY (3-36), PORCINE; PEPTIDE YY (3-36), HUMAN, SYNTHETIC >97%; peptide yy fragment 3-36 human; Peptide YY (3-36) (porcine, rat); M.W. 3980.44 C176H272N52O54; REF DUPL: H-ala-lys-Pro-Glu-ala-Pro-Gly-Glu-Asp-ala-Ser-Pro-Glu-Glu-leu-Ser-Arg-tyr-tyr-ala-Ser-leu-Arg-His-tyr-leu-Asn-leu-Val-Thr-Arg-Gln-Arg-tyr-NH2; ala-lys-PRO-GLU-ala-PRO-GLY-GLU-ASP-ala-SER-PRO-GLU-GLU-leu-SER-ARG-tyr-tyr-ala-SER-leu-ARG-HIS-tyr-leu-ASN-leu-VAL-THR-ARG-GLN-ARG-tyr-NH2 | ![]() | C176H272N52O54 | 详情 | 供应商 | |
| 121204-87-3 | [丙氨酸1,3,11,15]-内皮素1; [丙氨酸1,3,11,15]-内皮素1; ala-SER-ala-SER-SER-leu-MET-ASP-lys-GLU-ala-VAL- | H-ala-SER-ala-SER-SER-leu-MET-ASP-lys-GLU-ala-VAL-tyr-PHE-ala-HIS-leu-ASP-ILE-ILE-TRP-OH; H-ala-SER-ala-SER-SER-leu-MET-ASP-lys-GLU-ala-VAL-tyr-PHE-ala-HIS-leu-ASP-ILE-ILE-TRP-OH; ASASSLMDKEAVYFAHLDIIW; 4 ala ET-1; [ala1,3,11,15]-ENDOTHELIN; (ala1,3,11,15)-ENDOTHELIN-1; [ala1,3,11,15] ENDOTHELIN-1, HUMAN; [ala1,3,11,15]ENDOTHELIN-I; [ala1,3,11,16]-ENDOTHELIN 1, HUMAN | ![]() | C109H163N25O32S | 详情 | 供应商 |
| 87549-54-0 | ala-PRO-ARG-leu-ARG-PHE-tyr; bag cell peptide (Aplysia) (1-7); alaNINE-PROLINE-ARGININE-leuCINE-ARGININE-PHENYLalaNINE-tyrOSINE | ![]() | C44H67N13O9 | 详情 | 供应商 | |
| 600171-68-4 | ORPHAN GPCR SP9155 AGONIST P518 (HUMAN) | H-THR-SER-GLY-PRO-leu-GLY-ASN-leu-ala-GLU-GLU-leu-ASN-GLY-tyr-SER-ARG-lys-lys-GLY-GLY-PHE-SER-PHE-AR; H-THR-SER-GLY-PRO-leu-GLY-ASN-leu-ala-GLU-GLU-leu-ASN-GLY-tyr-SER-ARG-lys-lys-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2; ORPHAN GPCR SP9155 AGONIST P518 (HUMAN); ORPHAN G-PROTEIN COUPLED RECEPTOR SP9155 AGONIST PEPTIDE P518 (HUMAN); P518 (HUMAN); Orphan GPCR SP9155 Agonist P518 (huMan) P518 (huMan), Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P518 (huMan) | ![]() | 详情 | 供应商 | |
| 131448-51-6 | tyr-PRO-SER-lys-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ala-PRO-ala-GLU-ASP-MET-ala-ARG-tyr-tyr-SER-ala-leu-NH2; | H-tyr-PRO-SER-lys-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ala-PRO-ala-GLU-ASP-MET-ala-ARG-tyr-tyr-SER-ala-leu-NH; NPY (1-24) AMIDE (HUMAN, RAT); NPY (1-24) (HUMAN); NEUROPEPTIDE Y FRAGMENT 1-24 AMIDE HUMAN; NEUROPEPTIDE Y (1-24) AMIDE, HUMAN; NEUROPEPTIDE Y (1-24) AMIDE (HUMAN, RAT); NEUROPEPTIDE Y (1-24) (HUMAN); YPSKPDNPGEDAPAEDMARYYSAL-NH2; tyr-PRO-SER-lys-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ala-PRO-ala-GLU-ASP-MET-ala-ARG-tyr-tyr-SER-ala-leu-NH2 | ![]() | 详情 | 供应商 | |
| 150138-78-6 | NEUROPEPTIDE Y (3-36) (HUMAN, RAT); SER-lys-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ala-PRO-ala-GLU-ASP-MET-ala-A | H-SER-lys-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ala-PRO-ala-GLU-ASP-MET-ala-ARG-tyr-tyr-SER-ala-leu-ARG-HIS-TY; SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2; NEUROPEPTIDE Y FRAGMENT 3-36 HUMAN, RAT; NEUROPEPTIDE Y (3-36) HUMAN; NEUROPEPTIDE Y (3-36) (HUMAN, RAT); NPY (3-36), HUMAN; NPY (3-36) (HUMAN, RAT); H-SER-lys-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ala-PRO-ala-GLU-ASP-MET-ala-ARG-tyr-tyr-SER-ala-leu-ARG-HIS-tyr-ILE-ASN-leu-ILE-THR-ARG-GLN-ARG-tyr-NH2; NPY 3-36 | 无 | 详情 | 供应商 | |
| 130154-64-2 | (TRP63,TRP64)-C3A (63-77) | H-TRP-TRP-GLY-lys-lys-tyr-ARG-ala-SER-lys-leu-GLY-leu-ala-ARG-OH; [TRP63,64]-C3A (63-77); (TRP63,TRP64)-C3A (63-77); TRP-TRP-GLY-lys-lys-tyr-ARG-ala-SER-lys-leu-GLY-leu-ala-ARG; WWGKKYRASKLGLAR; H-TRP-TRP-GLY-lys-lys-tyr-ARG-ala-SER-lys-leu-GLY-leu-ala-ARG-OH | ![]() | 详情 | 供应商 | |